Cáncer de Próstataencontrar mimedicamentoscáncerImpact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk diseaseSix-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate CancerSix-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate CancerIntensity-Modulated Radiotherapy As Primary Treatment For Prostate Cancer: Acute Toxicity In 114 Patients10-Year Outcome for Men with Localized Prostate Cancer Treated with External Radiation Therapy: Results of a Cohort Study.Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen EraA randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancerThe Role of Androgen Deprivation in the Definitive Management of Clinically Localized Prostate Cancer Treated with Radiation TherapyRadiation Therapy for Clinically Localized Prostate Cancer: A Multi-Institutional Pooled AnalysisComparison of Radiation Side-Effects of Conformal and Conventional Radiotherapy in Prostate Cancer: a Randomised TrialA Prospective Study Of The Serum Prostate Specific Antigen Concentrations And Gleason Histologic Scores Of Black And White Men With Prostate Carcinomaß-Carotene Supplementation for Patients with Low Baseline Levels and Decreased Risks of Total and Prostate CarcinomaAmerican Brachytherapy Society (ABS) Recommendations for Transperineal Permanent Brachytherapy of Prostate CancerLong-Term Results Of A Randomized Trial For The Treatment Of Stages B2 And C Prostate Cancer: Radical Prostatectomy Versus External Beam Radiation Therapy With A Common Endocrine Therapy In Both ModalitiesThe Effect of Androgen Deprivation on the Early Changes in Prostate Volume Following Transperineal Ultrasound Guided Interstitial Therapy for Localized Carcinoma of the ProstateDetection of Prostate Cancer: Serendipity Strikes AgainSecond Primary Tumors after Prostate CarcinomaUrinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate CancerA comparison of External Beam Radiation Therapy versus Radical Prostatectomy for Patients with Low Risk Prostate Carcinoma Diagnosed, Staged, and Treated at a Single InstitutionProstate Specific Antigen Bounce after Radioactive Seed Implantation Followed by External Beam Radiation for Prostate CancerLaparoscopic Radical Prostatectomy: Preliminary ResultsBiochemical Failure does not Predict Overall Survival after Radical Prostatectomy for Localized Prostate Cancer: 10-year ResultsPercentage of Free PSA in Black versus White Men for Detection and Staging of Prostate Cancer: A Prospective Multicenter Clinical TrialSeminal Vesicle-Sparing Radical Prostatectomy: A Novel Concept to Restore Early Urinary ContinencePost-treatment PSA </= 0.2 ng/mL Defines Disease Freedom After Radiotherapy for Prostate Cancer Using Modern TechniquesDoes Prolonged Combined Androgen Blockade Have Survival Benefits Over Short-Term Combined Androgen Blockade Therapy?Extensive Biopsy Protocol Improves the Detection Rate of Prostate CancerHealth Outcomes after Prostatectomy or Radiotherapy for Prostate Cancer: Results From the Prostate Cancer Outcomes StudyCost-Effectiveness of Androgen Suppression Therapies in Advanced Prostate CancerComparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer DetectionSignificance of the CAG Repeat Polymorphism of the Androgen Receptor Gene in Prostate Cancer ProgressionCombined Androgen Blockade with Nonsteroidal Antiandrogens for Advanced Prostate Cancer: A Systematic ReviewUpdated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostateThe bicalutamide Early Prostate Cancer Program. DemographyUpdated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostateTherapeutic Radiation in Patients With a Rising Post-Prostatectomy PSA LevelProstate Cancer And Supplementation With Alpha-Tocopherol And Beta-Carotene: Incidence And Mortality In A Controlled TrialClinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate CancerBiochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerBilateral Orchiectomy with or without Flutamide for Metastatic Prostate CancerProstate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen ablationImproved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy andGoserelinRadical Surgery versus Radiotherapy for Adenocarcinoma of the ProstateClinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: A preliminary studyOsteoporosis in men treated with androgen deprivation therapy for prostate cancerTestosterone Recovery Following Prolonged Adjuvant Androgen Ablation for Prostate Carcinoma
Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease
Six-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate Cancer
Six-month Androgen Suppression Plus Radiation Therapy vs. Radiation Therapy Alone for Patients with Clinically Localized Prostate Cancer
Intensity-Modulated Radiotherapy As Primary Treatment For Prostate Cancer: Acute Toxicity In 114 Patients
10-Year Outcome for Men with Localized Prostate Cancer Treated with External Radiation Therapy: Results of a Cohort Study.
Temporarily Deferred Therapy (watchful waiting) for Men Younger Than 70 Years and With Low-Risk Localized Prostate Cancer in the Prostate-Specific Antigen Era
A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer
The Role of Androgen Deprivation in the Definitive Management of Clinically Localized Prostate Cancer Treated with Radiation Therapy
Comparison of Radiation Side-Effects of Conformal and Conventional Radiotherapy in Prostate Cancer: a Randomised Trial
A Prospective Study Of The Serum Prostate Specific Antigen Concentrations And Gleason Histologic Scores Of Black And White Men With Prostate Carcinoma
ß-Carotene Supplementation for Patients with Low Baseline Levels and Decreased Risks of Total and Prostate Carcinoma
American Brachytherapy Society (ABS) Recommendations for Transperineal Permanent Brachytherapy of Prostate Cancer
Long-Term Results Of A Randomized Trial For The Treatment Of Stages B2 And C Prostate Cancer: Radical Prostatectomy Versus External Beam Radiation Therapy With A Common Endocrine Therapy In Both Modalities
The Effect of Androgen Deprivation on the Early Changes in Prostate Volume Following Transperineal Ultrasound Guided Interstitial Therapy for Localized Carcinoma of the Prostate
A comparison of External Beam Radiation Therapy versus Radical Prostatectomy for Patients with Low Risk Prostate Carcinoma Diagnosed, Staged, and Treated at a Single Institution
Prostate Specific Antigen Bounce after Radioactive Seed Implantation Followed by External Beam Radiation for Prostate Cancer
Biochemical Failure does not Predict Overall Survival after Radical Prostatectomy for Localized Prostate Cancer: 10-year Results
Percentage of Free PSA in Black versus White Men for Detection and Staging of Prostate Cancer: A Prospective Multicenter Clinical Trial
Post-treatment PSA </= 0.2 ng/mL Defines Disease Freedom After Radiotherapy for Prostate Cancer Using Modern Techniques
Does Prolonged Combined Androgen Blockade Have Survival Benefits Over Short-Term Combined Androgen Blockade Therapy?
Health Outcomes after Prostatectomy or Radiotherapy for Prostate Cancer: Results From the Prostate Cancer Outcomes Study
Comparative Efficiency of Prostate-Specific Antigen Screening Strategies for Prostate Cancer Detection
Significance of the CAG Repeat Polymorphism of the Androgen Receptor Gene in Prostate Cancer Progression
Combined Androgen Blockade with Nonsteroidal Antiandrogens for Advanced Prostate Cancer: A Systematic Review
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
Prostate Cancer And Supplementation With Alpha-Tocopherol And Beta-Carotene: Incidence And Mortality In A Controlled Trial
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Prostate cancer in African-American men: Outcome following radiation therapy with or without adjuvant androgen ablation
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy andGoserelin
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: A preliminary study